19 Jun 2020 07:00
Catenae Innovation PLC
("Catenae", or the "Company")
Cov-ID Project Update
Further to the announcement on 29 May 2020, Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, announces that its occupational health and wellness partner, Newcastle Premier Health Limited ("NPH") has completed the proof of concept pilot trial of the Company's Cov-ID app (the "Cov-ID Project").
NPH provided its clinical expertise to the Cov-ID Project and has been piloting the app since 29 May 2020.
The Cov-ID app is a COVID-19 status verification passport, designed to support the efforts of businesses and organisations in getting back to work, whilst safeguarding employees from the spread of COVID-19 by allowing the user ("Certificate Holder") to share and prove their COVID-19 status in a secure, immutable and GDPR compliant manner.
The objective of the pilot trial was to undertake a "proof of concept" of the app to determine that user management, certification management and user validation achieved their functionality targets which included, inter alia - importing, creating and archiving certificate and user data and viewing data via secure means through both one-way and two-way validation processes.
Both the one-way and two-way validation processes work across Android and iOS platforms.
The app allows a Certificate Holder to expose their COVID-19 anti-body testing status to a third-party "gate-keeper" via a single use QR code displayed on their device.
In one-way validation, the QR code is readable by any device equipped with QR scanner functionality or app. In two-way validation mode both the gate-keeper and the Certificate Holder use the app allowing the identity of the gate-keeper to be validated and restricting the display of the Certificate Holder's status solely to the gate-keeper. Additionally the event is logged and recorded to a blockchain repository.
The Cov-ID project is a joint initiative by a consortium of companies led by the Z/Yen Group.
Although the proof of concept stage of the app has been positive, there is no guarantee that it will be commercialised, nor that in the event that it is commercialised, that material revenues will be generated by the Company.
Guy Meyer, Interim Chief Executive Officer of Catenae, said: "We are really pleased that NPH has completed the proof of concept in the Company's Cov-ID Project. The scope of the pilot trial was ambitiously expanded midway through to include the one-way validation usage on top of the initial two-way validation usage objective. Some minor graphic design refinements, based on NPH's feedback, will be completed within the next three weeks and then the Cov-ID app will be ready to be rolled out commercially across the UK and beyond to the benefit of businesses and organisations alike as the nations of the world begin to return to a semblance of normality.
I look forward to updating the market with further progress shortly."
Mark Philpott, Managing Director of Newcastle Premier Health Limited said: "We are pleased that the Cov-ID app performed well as part of our 'Controlled Access and Testing Programme', a carefully structured 'return to work pathway', which will give our business clients and their employees the reassurance they need when entering the workplace."
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Interim Chief Executive Officer of the Company.
- Ends -
For further information please contact:
Catenae Innovation PLC | +44 (0)191 580 8545 |
Guy Meyer, Interim CEO | |
Cairn Financial Advisers LLP (Nominated Adviser) | +44(0)20 7213 0880 |
Liam Murray / Jo Turner | |
| |
Brandon Hill Capital Limited, Broker | +44 (0)20 3463 5000 |
Andy Gutmann | +44 (0)78796 8313 |
Yellow Jersey PR (PR & IP) | +44 (0)20 3004 9512 |
Sarah Hollins / Annabel Atkins |
Notes to Editors:
About Catenae Innovation PLC
Catenae Innovation is an AIM quoted provider of digital media and technology services. The Company specialises in Distributed Ledger Technology solutions that solve commercial challenges and create opportunities for its clients. The Company has an experienced IT team of project managers and integrators who have deployed systems across corporate, government and educational sectors.
www.catenaeinnovation.com
About NPH Group
The NPH Group are a leading healthcare provider based in the North East of England. NPH offer COVID -19 strategic consultancy to global clients and UK testing services nationally. In addition to a full range of professional Occupational Health and Wellbeing services, they help businesses and organisations achieve their strategic personnel goals, ensuring business remain compliant and productive.
www.newcastlepremierhealth.com